Abstract
Estrogen (ER) and progesterone (PgR) receptors were assayed by histochemistry in primary, recurrent, and metastatic breast cancer. Ligand‐conjugates composed of 17β‐estradiol and 11α‐hydroxyprogesterone covalently linked to bovine serum albumin and labelled with fluorescin isothiocyanate were employed. Results were compared with those of conventional biochemical receptor assays and correlated for ER in 92% of 314 tumors and for PgR in 86% of 86 specimens. ER and PgR determinations by both assay systems were correlated with clinical response to various endocrine therapies in 40 women with Stage IV disease. The histochemical assay enabled successful prediction of response in 80% of cases including eight which could not be fully analyzed biochemically.
| Original language | English |
|---|---|
| Pages (from-to) | 2896-2901 |
| Number of pages | 6 |
| Journal | Cancer |
| Volume | 46 |
| Issue number | 12 S |
| DOIs | |
| State | Published - 15 Dec 1980 |
| Externally published | Yes |